PureTech Health (PRTC) Accounts Payables (2019 - 2025)
PureTech Health (PRTC) reported Accounts Payables of $23.2 million for Q4 2025, down 14.19% year-over-year from $27.0 million in Q4 2024, and up 23.2% on a QoQ basis from $18.8 million in Q2 2025.
PureTech Health (PRTC) has 7 years of Accounts Payables data on file, last reported at $23.2 million in Q4 2025.
- Quarterly Accounts Payables fell 14.19% year-over-year to $23.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.2 million (down 14.19% YoY) and the FY2025 annual result came in at $23.2 million, down 14.19% from the prior year.
- Accounts Payables advanced to $23.2 million in Q4 2025 per PRTC's latest filing, from $18.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $35.8 million in Q4 2021 and bottomed at $1.4 million in Q4 2022.
- The 5-year median for Accounts Payables is $21.0 million (2025), against an average of $20.2 million.
- The widest annual swing landed in 2022, when Accounts Payables sank 96.07%; it then jumped 971.64% in 2023.
- Tracing PRTC's Accounts Payables over 5 years: stood at $35.8 million in 2021, then slumped by 96.07% to $1.4 million in 2022, then jumped by 971.64% to $15.1 million in 2023, then jumped by 79.2% to $27.0 million in 2024, then retreated by 14.19% to $23.2 million in 2025.
- Per Business Quant, the three latest PRTC Accounts Payables figures stand at $23.2 million (Q4 2025), $18.8 million (Q2 2025), and $27.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 23.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.19 Mn |
| Jun 30, 2025 | 18.82 Mn |
| Dec 31, 2024 | 27.02 Mn |
| Dec 31, 2023 | 15.08 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Dec 31, 2021 | 35.76 Mn |
| Dec 31, 2020 | 20.57 Mn |
| Dec 31, 2019 | 19.84 Mn |